National Cancer Institute
Bethesda, United States
Dr. Andrea Gross is a board-certified pediatric hematologist-oncologist who earned her medical degree at the University of Connecticut and completed pediatric residency and a chief resident year at Cincinnati Children’s Hospital Medical Center. She completed a pediatric hematology/oncology fellowship at Children’s National Medical Center and is currently an Assistant Research Physician working in the Pediatric Oncology Branch at the National Cancer Institute in the lab of Dr. Brigitte Widemann. Her research focuses on developing new therapeutics through clinical trials for tumor predisposition syndromes, such as neurofibromatosis type 1 (NF1). Her areas of interest include developing and utilizing functional outcome measures for tumor predisposition syndromes with a focus on how to define clinical benefit in these conditions and working with rare disease patient advocates to increase patient engagement in clinical trial design.